RemeGen Biosciences

RemeGen Biosciences is a biopharmaceutical company headquartered in South San Francisco, California. As a wholly owned subsidiary of RemeGen, the company employs 42 individuals. RemeGen Biosciences focuses on the discovery, development, and commercialization of novel biologics. These treatments target autoimmune, oncology, and ophthalmic diseases with significant unmet medical needs. The company utilizes innovative target discovery strategies, advanced molecule design, and protein engineering platforms to create first-in-class and/or best-in-class biotherapeutics. Their goal is to provide patients with more effective therapies in a timely manner. For more information about RemeGen Biosciences, please visit their website at remegenbio.com.